TAENIASIS

TAENIASIS was reported 42 times

TAENIASIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anthelmintic [EPC] 4 0.0014
1 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 6 0.0001
2 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0001
3 Potassium-sparing Diuretic [EPC] 1 0.0001
4 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 6 0.0001
5 Interleukin-17A Antagonist [EPC] 2 0.0001
6 Recombinant Human Growth Hormone [EPC] 1 0.0000
7 Androgen [EPC] 1 0.0000
8 Microtubule Inhibitor [EPC] 6 0.0000
9 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
10 Copper-containing Intrauterine Device [EPC] 1 0.0000
11 Mood Stabilizer [EPC] 4 0.0000
12 Anti-epileptic Agent [EPC] 3 0.0000
13 Integrin Receptor Antagonist [EPC] 1 0.0000
14 Anti-IgE [EPC] 1 0.0000
15 Vascular Endothelial Growth Factor Inhibitor [EPC] 2 0.0000
16 Prostaglandin Analog [EPC] 1 0.0000
17 Corticosteroid [EPC] 13 0.0000
18 Aminosalicylate [EPC] 1 0.0000
19 Aromatase Inhibitor [EPC] 1 0.0000
20 Fluoroquinolone Antibacterial [EPC] 1 0.0000
21 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
22 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
23 alpha-Adrenergic Blocker [EPC] 1 0.0000
24 Calcium [EPC] 1 0.0000
25 beta-Adrenergic Blocker [EPC] 2 0.0000
26 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
27 Estrogen [EPC] 1 0.0000
28 Thiazide Diuretic [EPC] 1 0.0000
29 Alkylating Drug [EPC] 1 0.0000
30 Opioid Agonist [EPC] 1 0.0000
31 Platinum-based Drug [EPC] 1 0.0000
32 Platelet Aggregation Inhibitor [EPC] 2 0.0000
33 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
34 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
35 Insulin Analog [EPC] 1 0.0000
36 Atypical Antipsychotic [EPC] 1 0.0000
37 Kinase Inhibitor [EPC] 1 0.0000
38 Proton Pump Inhibitor [EPC] 1 0.0000
39 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
40 Benzodiazepine [EPC] 1 0.0000